Pfizer, BioNTech now siccing experimental COVID shots on babies
Pfizer Inc. and its German partner BioNTech announced an application to the Food and Drug Administration for approval — again, under an emergency use authorization — of the newest COVID-19-tied experimental shot, err, oops, vaccine for, get this, little kids, ages 6 months through 4 years old. Get ‘em while they’re young! That’s the slogan of street dealers, too. But...